✦ LIBER ✦

Decreased rejection episodes in african-american renal transplant recipients receiving mycophenolate mofetil/tacrolimus therapy

✍ Scribed by M. Weber; S. Deng; J. Arenas; S. Aradhye; R. Grossman; L. Shaw; A. Naji; C. Barker; K.L. Brayman

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Does Mycophenolate Mofetil Decrease the

✍ Aneesh Srivastava; Vishwajeet Singh; Devendra Kumar; Anant Kumar; R K Sharma 📂 Article 📅 2005 🏛 Springer Netherlands 🌐 English ⚖ 167 KB

The Use of Daclizumab, Tacrolimus and My

✍ Gaetano Ciancio; George W. Burke; Kiliana Suzart; Adela Mattiazzi; Anil Vaidya; 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB

Mycophenolate mofetil, along with ATG an

✍ J.M Puig; J Lloveras; P Fernández-Crespo; M Mir; V Iñigo; J.M Manresa; J Masramó 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Influence of tacrolimus plus mycophenola

✍ A Demirbaş; M Tuncer; A Yavuz; A Gürkan; S Kaçar; R Çetinkaya; S Tekin; S.H Akba 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Mycophenolate mofetil/neoral/steroid vs

✍ M Carmellini; F Vistoli; R Bellini; U Boggi; P Rindi; G Rizzo; F Mosca 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 79 KB

Single center analysis of mycophenolate

✍ M. Weber; R.J. Ketchum; M. Sellers; S. Aradhye; S. Deng; R. Grossman; L. Shaw; A 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 220 KB